微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 32.91% | 105.3% | 73.76% | 1/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 18.94% | 96.47% | 116.46% | 2/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 8.75% | 331.03% | -58.67% | 2/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 21.17% | 43.04% | 32.06% | 5/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 16.03% | 43.25% | 66.29% | 7/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 9.64% | 75.91% | 374.88% | 8/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.03% | 63.71% | -86.28% | 57/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 14.8% | 1.37% | 32.26% | 10/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 11.19% | -21.09% | 104.2% | 19/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.48% | -41.14% | 341.94% | 34/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.24% | -76.91% | -91.51% | 80/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 14.6% | -39.77% | 2.96% | 19/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 14.18% | -32.19% | 52.31% | 14/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 9.31% | -18.12% | 73.37% | 12/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 5.37% | 13.05% | -77.85% | 11/159 | 1.57% | 人福医药 | 6.82% | 行业排名> |
| 2021-12-31 | 24.24% | 72.9% | 15.93% | 8/159 | 0.75% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 20.91% | 130.29% | 83.91% | 3/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 11.37% | 337.31% | 139.37% | 10/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 4.75% | 351.32% | -66.12% | 16/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 14.02% | 135.23% | 54.41% | 34/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 9.08% | 75.97% | 249.23% | 39/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.6% | 256.16% | 237.57% | 79/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -1.89% | -1094.74% | -131.71% | 103/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 5.96% | 204.08% | 15.5% | 80/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 5.16% | 115% | 606.85% | 66/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.73% | 228.07% | 284.21% | 102/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.19% | 140.43% | -90.31% | 100/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 1.96% | -70.66% | -18.33% | 109/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 2.4% | -69.11% | 521.05% | 90/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | -0.57% | -110.98% | -21.28% | 101/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | -0.47% | -129.01% | -107.04% | 96/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 6.68% | -33.53% | -14.03% | 73/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 7.77% | -10.59% | 49.71% | 44/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 5.19% | -18.4% | 220.37% | 41/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.62% | 2% | -83.88% | 50/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 10.05% | 112.03% | 15.65% | 58/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 8.69% | 58.87% | 36.64% | 31/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 6.36% | 2% | 34.18% | 32/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2015-12-31 | 4.74% | 15.89% | 15.89% | 73/159 | 11.27% | 贝达药业 | 16.78% | 行业排名> |